V, O., V, S., M, M., S, L., V, L., M, Z., . . . F, C. (2024). Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination. Frontiers in immunology, 15, 1416464. https://doi.org/10.3389/fimmu.2024.1416464
Chicago Style (17th ed.) CitationV, Orrù, et al. "Implications of Disease-modifying Therapies for Multiple Sclerosis on Immune Cells and Response to COVID-19 Vaccination." Frontiers in Immunology 15 (2024): 1416464. https://doi.org/10.3389/fimmu.2024.1416464.
MLA (9th ed.) CitationV, Orrù, et al. "Implications of Disease-modifying Therapies for Multiple Sclerosis on Immune Cells and Response to COVID-19 Vaccination." Frontiers in Immunology, vol. 15, 2024, p. 1416464, https://doi.org/10.3389/fimmu.2024.1416464.